Osmotic Nephrosis: Acute Kidney Injury With Accumulation of Proximal Tubular Lysosomes Due to Administration of Exogenous Solutes

American Journal of Kidney Diseases

Volumn 51, Issue 3, 2008, Pages 491-503

  Dickenmann, Michael ^a   Oettl, Tobias ^a   Mihatsch, Michael J ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

acute kidney injury; Osmotic nephrosis

Indexed keywords

CALCINEURIN INHIBITOR; CONTRAST MEDIUM; DEXTRAN; ETHYLENE GLYCOL; HETASTARCH; IMMUNOGLOBULIN; MANNITOL; OSMOTIC AGENT; RAPAMYCIN; SUCROSE;

ACUTE DISEASE; ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; LYSOSOME; NEPHROSIS; PATHOPHYSIOLOGY; SOLUTE;

ANIMALS; ANTICOAGULANTS; DEXTRANS; DIAGNOSIS, DIFFERENTIAL; DIURETICS, OSMOTIC; EPITHELIAL CELLS; HETASTARCH; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY GLOMERULUS; KIDNEY TUBULES, PROXIMAL; LYSOSOMES; MANNITOL; NEPHROSIS; OSMOTIC PRESSURE; RECOVERY OF FUNCTION; RISK FACTORS; VACUOLES;

EID: 39449121319     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.10.044     Document Type: Article

References (164)

1. Allen A.C. Diseases of the tubules. In: Grune, and Stratton I. (Eds). The Kidney: Medical and Surgical Diseases (1951), Grune & Stratton, New York, NY 207-298
2. Janssen Jr. C.W. Osmotic nephrosis. A clinical and experimental investigation. Acta Chir Scand 134 (1968) 481-487
3. Blullock L.T., Gregersen M.L., and Kinney R. The use of hypertonic sucrose solution intravenously to reduce cerebrospinal fluid pressure without a secondary rise. Am J Physiol 112 (1935) 82-86
4. Massermann J.H. Effects of the intravenous administration of hypertonic solution of sucrose with special reference to cerebrospinal fluid pressure. Bull Johns Hopkins Hosp 57 (1935) 12-17
5. Helmholz H.F. Renal changes in the rabbit resulting from intravenous injection of hypertonic solution of sucrose. J Pediatr 3 (1933) 144-157
6. Anderson A.A., and Bethea W.R. Renal lesions following administration of hypertonic solutions of sucrose. J Am Med Assoc 114 (1940) 1983-1987
7. Zollinger H.U. Niere und ableitende Harnwege (1966), Springer Verlag, New York, NY
8. Maunsbach A.B., Madden S.C., and Latta H. Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran. Lab Invest 11 (1962) 421-432
9. Zollinger H.U., and Mihatsch M.J. Renal Pathology in Biopsy (1978), Springer Verlag, Berlin, Germany
10. Trump B.F., and Janigan D.T. The pathogenesis of cytologic vacuolization in sucrose nephrosis. An electron microscopic and histochemical study. Lab Invest 11 (1962) 395-411
11. Rohr H.P., and Zollinger H.U. [The so-called "sugar storing kidney" with special consideration of electron microscopic autoradiographic studies with C-14 saccharose]. Virchows Arch Pathol Anat Physiol Klin Med 341 (1966) 115-122
12. Cornu P., Caulin C., Marsan C., et al. [Osmotic nephropathy. Specific iatrogenic disease or nonspecific tubular reaction?. ] Sem Hop 49 (1973) 1429-1430
13. Dorman H.R., Sondheimer J.H., and Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore) 69 (1990) 153-159
14. Mihatsch M.J., Thiel G., and Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 20 (1988) 759-771
15. Fillastre J.P., Mignon F., Sraer J.D., et al. [Acute reversible renal insufficiency after prolonged treatment with dextran]. Presse Med 75 (1967) 2535-2538
16. Lampe W.T. Interstitial nephritis: Reversibility of osmotic changes due to mannitol proved by biopsy. Angiology 16 (1965) 281-287
17. Ryffel B., Foxwell B.M., Gee A., et al. Cyclosporine-Relationship of side effects to mode of action. Transplantation 46 suppl 2 (1988) S90-S96
18. Hess R., Bartels M.J., and Pottenger L.H. Ethylene glycol: An estimate of tolerable levels of exposure based on a review of animal and human data. Arch Toxicol 78 (2004) 671-680
19. Schwartz S.L., and Johnson C.B. Pinocytosis as the cause of sucrose nephrosis. Nephron 8 (1971) 246-254
20. Chacko B., John G.T., Balakrishnan N., et al. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy. Ren Fail 28 (2006) 193-195
21. Kwan T.H., Tong M.K., Siu Y.P., et al. Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman. Hong Kong Med J 11 (2005) 45-49
22. Diomi P., Ericsson J.L., and Matheson N.A. Effects of dextran 40 on urine flow and composition during renal hypoperfusion in dogs with osmotic nephrosis. Ann Surg 172 (1970) 813-824
23. Engberg A., and Ericsson J.L. Effects of dextran 40 on proximal renal tubule. Electron microscopic and cytochemical studies in the mouse. Acta Chir Scand 135 (1969) 263-274
24. Engberg A. Effects of dextran 40 on the proximal renal tubule. Studies on transfer maxima of glucose and hippuran in the rat. Acta Chir Scand 142 (1976) 172-180
25. Christensen E.I., and Maunsbach A.B. Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule. Kidney Int 16 (1979) 301-311
26. Christensen E.I., and Maunsbach A.B. Dextran is resistant to lysosomal digestion in kidney tubules. Virchows Arch B Cell Pathol Incl Mol Pathol 37 (1981) 49-59
27. Tervahartiala P., Kivisaari L., Kivisaari R., et al. Contrast media-induced renal tubular vacuolization. A light and electron microscopic study on rat kidneys. Invest Radiol 26 (1991) 882-887
28. Tervahartiala P. Contrast media-induced renal tubular vacuolization after dehydration. A light and electron microscopic study in rats. Invest Radiol 27 (1992) 114-118
29. Nordby A., Tvedt K.E., Halgunset J., et al. Intracellular penetration and accumulation of radiographic contrast media in the rat kidney. Scanning Microsc 4 (1990) 651-664
30. Brezis M., Heyman S.N., and Epstein F.H. Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am J Physiol 267 (1994) F1063-F1068
31. Brezis M., Agmon Y., and Epstein F.H. Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 267 (1994) F1059-F1062
32. Heyman S.N., Brezis M., Epstein F.H., et al. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 40 (1991) 632-642
33. Palm F., Cederberg J., Hansell P., et al. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 46 (2003) 1153-1160
34. Garvin P.J., and Gargan B. Toxicity: Subacute toxicology of intravenous mannitol. In: Mazze R.I., and Barry K.G. (Eds). Abstracts of the Symposium on the Clinical and Experimental Use of Mannitol (1962), Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington DC
35. Hofmeister R., Bhargava A.S., and Gunzel P. The use of urinary N-acetyl-beta-d-glucosaminidase (NAG) for the detection of contrast-media-induced 'osmotic nephrosis' in rats. Toxicol Lett 50 (1990) 9-15
36. Laurent G., Kishore B.K., and Tulkens P.M. Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol 40 (1990) 2383-2392
37. Merski J.A., and Meyers M.C. Light- and electron-microscopic evaluation of renal tubular cell vacuolation induced by administration of nitrilotriacetate or sucrose. Food Chem Toxicol 23 (1985) 923-930
38. Olier B., Morin J.P., Grancher G., et al. Regenerating tubular cell process in rat kidney: Influence of gentamicin treatment. Int J Tissue React 9 (1987) 241-250
39. Tervahartiala P., Kivisaari L., Kivisaari R., et al. Letter. Invest Radiol 28 (1993) 188-190
40. Diomi P., Engberg A., Ericsson J.L., et al. Studies on renal tubular morphology, toxicity and function after large doses of dextran 40 in the dog. Acta Chir Scand 135 (1969) 345-355
41. Morard J.C. [Experimental contribution to the study of osmotic nephrosis; Excess glucose; Excess water; Acute hyponatremia]. Helv Med Acta 23 (1956) 215-239
42. Moreau J.F., Droz D., Sabto J., et al. Osmotic nephrosis induced by water-soluble triiodinated contrast media in man. A retrospective study of 47 cases. Radiology 115 (1975) 329-336
43. Moreau J.F., Noel L.H., and Droz D. Proximal renal tubular vacuolization induced by iodinated contrast media, or so-called "osmotic nephrosis". Invest Radiol 28 (1993) 187-190
44. Food and Drug Administration (FDA): Renal insufficiency and failure associated with immune globulin intravenous therapy-United States, 1985-1998. MMWR Morbid Mortal Wkly Rep 48 (1999) 518-521z
45. Gras V., Andrejak M., and Decocq G. Acute renal failure associated with intravenous immunoglobulins. Pharmacoepidemiol Drug Saf 8 suppl 1 (1999) S73-S78
46. Barton J.C., Herrera G.A., Galla J.H., et al. Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Med 82 (1987) 624-629
47. Ahsan N., Palmer B.F., Wheeler D., et al. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med 154 (1994) 1985-1987
48. Cantu T.G., Hoehn-Saric E.W., Burgess K.M., et al. Acute renal failure associated with immunoglobulin therapy. Am J Kidney Dis 25 (1995) 228-234
49. Hansen-Schmidt S., Silomon J., and Keller F. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. Am J Kidney Dis 28 (1996) 451-453
50. Kobosko J., and Nicol P. Renal toxicity of intravenous immunoglobulin. Clin Nephrol 37 (1992) 216-217
51. Phillips A.O. Renal failure and intravenous immunoglobulin. Clin Nephrol 37 (1992) 217
52. Rault R., Piraino B., Johnston J.R., et al. Pulmonary and renal toxicity of intravenous immunoglobulin. Clin Nephrol 36 (1991) 83-86
53. Tan E., Hajinazarian M., Bay W., et al. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 50 (1993) 137-139
54. Tsinalis D., Dickenmann M., Brunner F., et al. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. Am J Kidney Dis 40 (2002) 667-670
55. Ahsan N., Wiegand L.A., Abendroth C.S., et al. Acute renal failure following immunoglobulin therapy. Am J Nephrol 16 (1996) 532-536
56. Khalil M., Shin H.J., Tan A., et al. Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy. A case report. Acta Cytol 44 (2000) 86-90
57. Winward D.B., and Brophy M.T. Acute renal failure after administration of intravenous immunoglobulin: Review of the literature and case report. Pharmacotherapy 15 (1995) 765-772
58. Brannagan III T.H., Nagle K.J., Lange D.J., et al. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 47 (1996) 674-677
59. Sati H.I., Ahya R., and Watson H.G. Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy. Br J Haematol 113 (2001) 556-557
60. Katz U., Achiron A., Sherer Y., et al. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev 6 (2007) 257-259
61. Taggart W.R., Thibodeau G.A., and Swanson R.N. Mannitol induced renal alterations in rabbits. S D J Med 21 (1968) 30-34
62. Stuart F.P., Torres E., Fletcher R., et al. Effects of single, repeated and massive mannitol infusion in the dog: Structural and functional changes in kidney and brain. Ann Surg 172 (1970) 190-204
63. Plouvier B., Baclet J.L., and de Coninck P. [A nephrotoxic combination: Mannitol and furosemide]. Nouv Presse Med 10 (1981) 1744-1745
64. Gadallah M.F., Lynn M., and Work J. Case report: Mannitol nephrotoxicity syndrome: Role of hemodialysis and postulate of mechanisms. Am J Med Sci 309 (1995) 219-222
65. Brunner F.P., Hermle M., Mihatsch M.J., et al. Mannitol potentiates cyclosporine nephrotoxicity. Clin Nephrol 25 suppl 1 (1986) S130-S136
66. Biesenbach G., Zazgornik J., Kaiser W., et al. Severe tubulopathy and kidney graft rupture after coadministration of mannitol and ciclosporin. Nephron 62 (1992) 93-96
67. Visweswaran P., Massin E.K., and DuBose Jr. T.D. Mannitol-induced acute renal failure. J Am Soc Nephrol 8 (1997) 1028-1033
68. Lin S.L., Hung K.Y., Wu F.L., et al. Mannitol-induced acute renal failure. Nephrol Dial Transplant 10 (1995) 120-122
69. Perez-Perez A.J., Pazos B., Sobrado J., et al. Acute renal failure following massive mannitol infusion. Am J Nephrol 22 (2002) 573-575
70. Better O.S., Rubinstein I., Winaver J.M., et al. Mannitol therapy revisited (1940-1997). Kidney Int 52 (1997) 886-894
71. Rabetoy G.M., Fredericks M.R., and Hostettler C.F. Where the kidney is concerned, how much mannitol is too much?. Ann Pharmacother 27 (1993) 25-28
72. Doi K., Ogawa N., Suzuki E., et al. Mannitol-induced acute renal failure. Am J Med 115 (2003) 593-594
73. Rello J., Triginer C., Sanchez J.M., et al. Acute renal failure following massive mannitol infusion. Nephron 53 (1989) 377-378
74. Horgan K.J., Ottaviano Y.L., and Watson A.J. Acute renal failure due to mannitol intoxication. Am J Nephrol 9 (1989) 106-109
75. Goldwasser P., and Fotino S. Acute renal failure following massive mannitol infusion. Appropriate response of tubuloglomerular feedback?. Arch Intern Med 144 (1984) 2214-2216
76. Weaver A., and Sica D.A. Mannitol-induced acute renal failure. Nephron 45 (1987) 233-235
77. Du J., Cao J., and Zhao H. [Mannital induced acute renal failure]. Zhonghua Wai Ke Za Zhi 34 (1996) 436-437
78. van Hengel P., Nikken J.J., de Jong G.M., et al. Mannitol-induced acute renal failure. Neth J Med 50 (1997) 21-24
79. Suzuki K., Miki M., Ono Y., et al. [Acute renal failure following mannitol infusion]. Hinyokika Kiyo 39 (1993) 721-724
80. Moran M., and Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317 (1987) 150-153
81. Arturson G., and Wallenius G. The renal clearance of dextran of different molecular sizes in normal humans. Scand J Clin Lab Invest 16 (1964) 81-86
82. Birke G., and Liljedahl S.O. [Kidney injuries in extensive burns with regard to treatment with rheomacrodex]. Schweiz Med Wochenschr 96 (1966) 525-533
83. Mailloux L., Swartz C.D., Capizzi R., et al. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med 277 (1967) 1113-1118
84. Morgan T., and Little J.M. Renal failure and low-molecular-weight dextran. Br Med J 1 (1967) 635
85. Matheson N.A., and Diomi P. Renal failure after the administration of dextran 40. Surg Gynecol Obstet 131 (1970) 661-668
86. Alvarez G.H., Oliva A.H., Lopez D.N., et al. [Acute renal failure caused by dextran of low molecular weight]. Rev Clin Esp 116 (1970) 169-172
87. Burgos-Calderon R., and Figueroa J.E. Acute oliguric renal failure associated with low-molecular-weight dextran. Bol Asoc Med P R 64 (1972) 1-4
88. Feest T.G. Low molecular weight dextran: A continuing cause of acute renal failure. Br Med J 2 (1976) 1300
89. Schwarz J., Ihle B., and Dowling J. Acute renal failure induced by low molecular weight dextran. Aust N Z J Med 14 (1984) 688-689
90. Zwaveling J.H., Meulenbelt J., van Xanten N.H., et al. Renal failure associated with the use of dextran-40. Neth J Med 35 (1989) 321-326
91. Druml W., Polzleitner D., Laggner A.N., et al. Dextran-40, acute renal failure, and elevated plasma oncotic pressure. N Engl J Med 318 (1988) 252-253
92. Kurnik B.R., Singer F., and Groh W.C. Case report: Dextran-induced acute anuric renal failure. Am J Med Sci 302 (1991) 28-30
93. Hardin C.K., Kirk W.C., and Pederson W.C. Osmotic complications of low-molecular-weight dextran therapy in free flap surgery. Microsurgery 13 (1992) 36-38
94. Matsushima H., Yonemura K., Nakamura T., et al. [Case of acute kidney failure induced low-molecular weight dextran effectively treated by plasma exchange]. Nippon Naika Gakkai Zasshi 83 (1994) 294-295
95. Morgan T.O., Little J.M., and Evans W.A. Renal failure associated with low-molecular-weight dextran infusion. Br Med J 2 (1966) 737-739
96. Biesenbach G., Kaiser W., and Zazgornik J. Incidence of acute oligoanuric renal failure in dextran 40 treated patients with acute ischemic stroke stage III or IV. Ren Fail 19 (1997) 69-75
97. Frey L., and Messmer K. Acute oligoanuric renal failure in dextran 40 treated patients. Ren Fail 20 (1998) 543-545
98. Brooks D., Okeefe P., and Buncke H.J. Dextran-induced acute renal failure after microvascular muscle transplantation. Plast Reconstr Surg 108 (2001) 2057-2060
99. Kato A., Yonemura K., Matsushima H., et al. Complication of oliguric acute renal failure in patients treated with low-molecular weight dextran. Ren Fail 23 (2001) 679-684
100. Vos S.C., Hage J.J., Woerdeman L.A., et al. Acute renal failure during dextran-40 antithrombotic prophylaxis: Report of two microsurgical cases. Ann Plast Surg 48 (2002) 193-196
101. Chinitz J.L., Kim K.E., Onesti G., et al. Pathophysiology and prevention of dextran-40-induced anuria. J Lab Clin Med 77 (1971) 76-87
102. Manning Jr. R.D. Effects of hypoproteinemia on renal hemodynamics, arterial pressure, and fluid volume. Am J Physiol 252 (1987) F91-F98
103. Goldenberg M., Crane D., and Popper H. Effect of intravenous administration of dextran, a macromolecular carbohydrate, in animals. Am J Clin Pathol 17 (1947) 939-948
104. Ishikawa E. [Experimental study of drug-induced acute renal failure. Recovery after renal impairment caused by the administration of low molecular weight dextran and kanamycin in water-deprived rats]. Hinyokika Kiyo 34 (1988) 215-224
105. Van Den Berg C.J., and Pineda A.A. Plasma exchange in the treatment of acute renal failure due to low molecular-weight dextran. Mayo Clin Proc 55 (1980) 387-389
106. Ferraboli R., Malheiro P.S., Abdulkader R.C., et al. Anuric acute renal failure caused by dextran 40 administration. Ren Fail 19 (1997) 303-306
107. Aspelin P., Aubry P., Fransson S.G., et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
108. Sandler C.M. Contrast-agent-induced acute renal dysfunction-Is iodixanol the answer?. N Engl J Med 348 (2003) 551-553
109. Pendergrass E.P., Chamberlain G.W., and Godfrey E.W. A survey of death and unfavorable sequelae following the administration of contrast media. Am J Radiol 48 (1942) 741-762
110. Rudnick M.R., Berns J.S., Cohen R.M., et al. Nephrotoxic risks of renal angiography: Contrast media-associated nephrotoxicity and atheroembolism-A critical review. Am J Kidney Dis 24 (1994) 713-727
111. Barrett B.J. Contrast nephrotoxicity. J Am Soc Nephrol 5 (1994) 125-137
112. Yoshioka T., Fogo A., and Beckman J.K. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 41 (1992) 1008-1015
113. Weisberg L.S., Kurnik P.B., and Kurnik B.R. Radiocontrast-induced nephropathy in humans: Role of renal vasoconstriction. Kidney Int 41 (1992) 1408-1415
114. Kramer B.K., Kammerl M., Schweda F., et al. A primer in radiocontrast-induced nephropathy. Nephrol Dial Transplant 14 (1999) 2830-2834
115. Niu G. [Experimental histopathological studies of renal lesions induced by high- or low-osmolality contrast media]. Nippon Ika Daigaku Zasshi 60 (1993) 390-405
116. Battenfeld R., Khater A., Drommer W., et al. Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats. Invest Radiol 26 (1991) 35-39
117. Tervahartiala P., Kivisaari L., Kivisaari R., et al. Contrast media-induced renal tubular vacuolization. A light and electron microscopic study on rat kidneys. Invest Radiol 26 (1991) 882-887
118. Tervahartiala P., Kivisaari R., and Virtanen I. Contrast media-induced renal morphologic changes in rats with acute edematous pancreatitis. Invest Radiol 27 (1992) 520-524
119. Tervahartiala P., Kivisaari L., Kivisaari R., et al. Contrast media-induced renal morphologic lesions during experimental hemorrhagic necrotizing pancreatitis. Invest Radiol 27 (1992) 1064-1068
120. Tervahartiala P. Contrast media-induced renal tubular vacuolization after dehydration. A light and electron microscopic study in rats. Invest Radiol 27 (1992) 114-118
121. Tervahartiala P., Kivisaari L., Kivisaari R., et al. Contrast media-induced renal morphologic lesions in diabetic rats. Acta Radiol 34 (1993) 220-225
122. Golman K., and Almen T. Contrast media-induced nephrotoxicity. Survey and present state. Invest Radiol 20 suppl 1 (1985) S92-S97
123. Heyman S.N., Brezis M., Reubinoff C.A., et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest 82 (1988) 401-412
124. Rees J.A., Old S.L., and Rowlands P.C. An ultrastructural histochemistry and light microscopy study of the early development of renal proximal tubular vacuolation after a single administration of the contrast enhancement medium "Iotrolan". Toxicol Pathol 25 (1997) 158-164
125. Gruskin A.B., Oetliker O.H., Wolfish N.M., et al. Effects of angiography on renal function and histology in infants and piglets. J Pediatr 76 (1970) 41-48
126. Kleinknecht D., Jungers P., Michel J.R., et al. [Complications of osmotic nephrosis after perfusion urography in renal insufficiency]. Ann Med Interne (Paris) 122 (1971) 1167-1171
127. Kleinknecht D., Landais P., and Goldfarb B. [Acute renal failure associated with drugs or iodinated contrast media. Results of a cooperative multicentric study by the Nephrology Society]. Nephrologie 7 (1986) 41-46
128. Moreau J.F., Droz D., Noel L.H., et al. Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 15 suppl 6 (1980) S54-S60
129. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure: Is a change of clinical practice indicated?. Drug Saf 25 (2002) 837-846
130. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 358 (2001) 581-583
131. De Labarthe A., Jacobs F., Blot F., et al. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111 (2001) 417-418
132. Peron S., Mouthon L., Guettier C., et al. Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol 55 (2001) 408-411
133. Dickenmann M.J., Filipovic M., Schneider M.C., et al. Hydroxyethylstarch-associated transient acute renal failure after epidural anaesthesia for labour analgesia and Caesarean section. Nephrol Dial Transplant 13 (1998) 2706
134. Godet G. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 358 (2001) 581
135. Gosling P., Rittoo D., Manji M., et al. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 358 (2001) 581
136. Schortgen F., Lacherade J.C., Bruneel F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 357 (2001) 911-916
137. Waldhausen P., Kiesewetter H., Leipnitz G., et al. [Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage]. Acta Med Austriaca 18 suppl 1 (1991) S52-S55
138. Haskell L.P., and Tannenberg A.M. Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration. N Y State J Med 88 (1988) 387-388
139. Vogt N.H., Bothner U., Lerch G., et al. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: Plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 83 (1996) 262-268
140. Ebcioglu Z., Cohen D.J., Crew R.J., et al. Osmotic nephrosis in a renal transplant recipient. Kidney Int 70 (2006) 1873-1876
141. Standl T., Lipfert B., Reeker W., et al. [Acute effects of complete blood exchange with ultra-purified hemoglobin solution or hydroxyethyl starch on liver and kidney in the animal model]. Anasthesiol Intensivmed Notfallmed Schmerzther 31 (1996) 354-361
142. Kief H., and Engelbart K. [Reabsorptive vacuolization of the contorted main parts of the kidney (so-called osmotic nephrosis)]. Frankf Z Pathol 75 (1966) 53-65
143. Cittanova M.L., Leblanc I., Legendre C., et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348 (1996) 1620-1622
144. Legendre C., Thervet E., Page B., et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342 (1993) 248-249
145. Deman A., Peeters P., and Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicentre analysis. Nephrol Dial Transplant 14 (1999) 1517-1520
146. Coronel B., Mercatello A., Colon S., et al. Hydroxyethyl starch and osmotic nephrosis-like lesions in kidney transplants. Lancet 348 (1996) 1595
147. Verhelst D., Moulin P., Haufroid V., et al. Acute renal injury following methanol poisoning: Analysis of a case series. Int J Toxicol 23 (2004) 267-273
148. Hamburger J., Halpern B., and Funk-Brentano J.L. Une varieté d'anuria provoquée par l'hydratation excessive des cellule renales. Nouv Presse 62 (1954) 972-976
149. Allen A.C. The Kidney: Medical and Surgical Diseases (1962), Grune & Stratton, New York, NY
150. Kief H., Engelbart K., Arnold G., et al. [Vacuolar reabsorption of native and digested gelatin (so-called osmotic nephrosis)]. Virchows Arch B Cell Pathol 1 (1968) 240-250
151. Kief H., Hajdu P., and Engelbart K. [Reabsortive vacuolization (so-called osmotic nephrosis) following inulin]. Frankf Z Pathol 77 (1967) 12-19
152. Simon G., Chatelanat F., and Falbriard A. Experimental nephrosis due to inulin: Light and electron microscopic studies. Lab Invest 13 (1964) 1381-1393
153. Lindberg H.A., Wald M.H., and Barker M.H. Renal changes following administration of hypertonic solutions. Arch Intern Med 63 (1939) 907
154. Träckner K. Experimentell Untersuchungen zur Frage der Peristonspeicherung in Mitochondrien der Nierentubuli. Zschr Ges Exp Med 123 (1954) 101
155. Ackermann R.H. [Effects of parenteral infusion of glycerol on glycerol kinase and adenosine triphosphate in rat kidneys (author's transl)]. Res Exp Med (Berl) 166 (1975) 251-263
156. Schifferli J., Leski M., Favre H., et al. High-dose intravenous IgG treatment and renal function. Lancet 337 (1991) 457-458
157. Goodwin W.E., and Latta H. Focal osmotic nephrosis due to the therapeutic use of mannitol: A case of perirenal hematoma after renal biopsy. J Urol 103 (1970) 11-14
158. Dalgaard O.Z., and Pedersen K.J. Some observations of the fine structure of human kidney biopsies in acute anuria and osmotic diuresis. In: Wolstenholme G.W., and Cameron M.P. (Eds). Renal Biopsy (1962), Little Brown, Boston, MA 126-132
159. Auquier L., Paolaggi J.B., Rouques C., et al. [Fatal anuria after perfusion of low molecular weight dextran]. Therapie 23 (1968) 751-754
160. Fournier A., Watchi J.M., and Reveillaud R.J. [So-called osmotic nephrosis or hydropic vacuolization in the proximal tubules]. Presse Med 77 (1969) 1987-1990
161. Evans W.A., and Wong D. Renal changes following the administration of low molecular weight dextran. Aust N Z J Surg 36 (1966) 69-73
162. Favre H., Giromini M., Gerster J.C., et al. [Anuria associated with low molecular dextran administration]. Schweiz Med Wochenschr 98 (1968) 1982-1984
163. Lamotte M., Roujeau J., Segrestaa J.M., et al. [A case of anuria from osmotic nephropathy after perfusions of low molecular weight dextran]. Sem Hop 44 (1968) 187-190
164. Cayco A.V., Perazella M.A., and Hayslett J.P. Renal insufficiency after intravenous immune globulin therapy: A report of two cases and an analysis of the literature. J Am Soc Nephrol 8 (1997) 1788-1794